Back to mobile site

UPDATE: SVB Leerink Upgrades Moderna (MRNA) to Market Perform, 'PFE Springs MRNA from the Penalty Box'

October 21, 2022 6:52 AM EDT Send to a Friend
(Updated - October 21, 2022 8:58 AM EDT)

SVB Leerink analyst Mani Foroohar upgraded Moderna (NASDAQ: MRNA) from Underperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login